• KOL
    • Rheumatoid Arthritis
    • Edward Keystone
    • Edward Keystone: Influence Statistics

      Edward Keystone

      Edward Keystone

      The Rebecca MacDonald Centre for Arthritis, Mount Sinai Hospital, Toronto, ON, Canada. | Mount Sinai Hospital Toronto, Ontario Canada

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Edward Keystone:Expert Impact

      Concepts for whichEdward Keystonehas direct influence:Rheumatoid arthritis,Inadequate response,Patients tofacitinib,Rheumatology patients,Tofacitinib patients,Patients rheumatoid arthritis,Safety tofacitinib,Treatment rheumatoid arthritis.

      Edward Keystone:KOL impact

      Concepts related to the work of other authors for whichfor which Edward Keystone has influence:Rheumatoid arthritis,Smartphone app,Patients tofacitinib,Small molecule inhibitors,Radiographic progression,Hoc analysis,Inadequate response.

      KOL Resume for Edward Keystone

      Year
      2022

      The Rebecca MacDonald Centre for Arthritis, Mount Sinai Hospital, Toronto, ON, Canada.

      2019

      Mount Sinai Hospital Toronto, Ontario Canada

      Sample of concepts for which Edward Keystone is among the top experts in the world.
      Concept World rank
      defined lda #32
      cdai defined #42
      initiating tofacitinib #52
      flaring patients #96
      flares rheumatoid arthritis #97
      flare status #97

      Prominent publications by Edward Keystone

      KOL-Index: 12528

      OBJECTIVE: Tofacitinib is an oral JAK inhibitor for the treatment of rheumatoid arthritis (RA). The phase III, 24-month, placebo-controlled Oral Rheumatoid Arthritis (ORAL) Scan trial was undertaken to evaluate the efficacy, including inhibition of structural progression, and safety of tofacitinib in patients with active RA and an inadequate response to methotrexate (MTX). Month 24 data from the completed study are reported here.

      METHODS: Patients were randomized 4:4:1:1 to receive ...

      Known for Tofacitinib Patients | Phase Iii | Safety Outcomes | Rheumatoid Drug Therapy | Agents Arthritis
      KOL-Index: 6310

      OBJECTIVE: To evaluate the reliability of concurrent flare identification using 3 methods (patient, rheumatologist and Disease Activity Score (DAS)28 criteria), and construct validity of candidate items representing the Outcome Measures in Rheumatology Clinical Trials (OMERACT) RA Flare Core Domain Set.

      METHODS: Candidate flare questions and legacy measures were administered at consecutive visits to Canadian Early Arthritis Cohort (CATCH) patients between November 2011 and November 2014. ...

      Known for Rheumatoid Arthritis | Patients Flare | Outcome Measures | Construct Validity | Disease Activity Score

      Key People For Rheumatoid Arthritis

      Top KOLs in the world
      #1
      Paul Emery
      rheumatoid arthritis ankylosing spondylitis radiographic progression
      #2
      Josef Sebastian Smolen
      rheumatoid arthritis systemic lupus erythematosus radiographic progression
      #3
      James F Fries
      rheumatoid arthritis physical function systemic lupus erythematosus
      #4
      John Turner Sharp
      rheumatoid arthritis radiographic progression joint space width
      #5
      Frederick J Wolfe
      rheumatoid arthritis work disability rheumatic diseases
      #6
      Matthew H Liang
      rheumatoid arthritis systemic lupus erythematosus lyme disease

      The Rebecca MacDonald Centre for Arthritis, Mount Sinai Hospital, Toronto, ON, Canada. | Mount Sinai Hospital Toronto, Ontario Canada

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.